L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?

E-ISSN： 1875-628x|2|7|558-562

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.7, 2005-11, pp. : 558-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperhomocysteinemia in L-Dopa Treated Patients with Parkinson's Disease: Potential Implications in Cognitive Dysfunction and Dementia?

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3253-3261

Bentham Science Publishers

Access to resources Recommend Favorite

Half a Century of l-DOPA

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 880-893

Bentham Science Publishers

Access to resources Recommend Favorite

Transdermal absorption of l-dopa from hydrogel in rats

By Lindner A. Sudo J.-i. Iwase H. Terui J. Kakuno K. Momoko Soyama Takayama K. Nagai T.

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 1, 1998-12 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

In Vitro Production Of L-dopa In Tissue Cultures Of Banana

By Bapat V.A. Suprasanna P. Ganapathi T.R. Rao P.S.

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 38, Iss. 4, 2000-10 ,pp. : 271-273

Informa Healthcare

Access to resources Recommend Favorite

Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity

Current Medicinal Chemistry, Vol. 22, Iss. 36, 2015-12 ,pp. : 4138-4165

Bentham Science Publishers

Access to resources Recommend Favorite